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Friedreich ataxia (FA) is an autosomal-recessive hereditary ataxia with a prevalence of around 
1 case per 30’000. It is a severely debilitating disease characterized by progressive gait and 
limb ataxia, dysarthria, lower-limb areflexia, muscular weakness and pyramidal signs, and is 
due to GAA triplet expansion in the frataxin (FXN) gene located on chromosome 9q13 1. 
Patients usually begin the disorder at puberty or before the age of 25 years in most studies, 
but rare cases of ‘Late-Onset Friedreich ataxia’ (LOFA) have been described. LOFA patients 
were recognized to have a median age of onset of 28.8 years (range of 25.5 to 48), have a 
milder phenotype and often retained lower limb reflexes 2,3. Very Late-Onset Friedreich ataxia 
(VLOFA) has also been reported 4,5, with the first manifestations appearing in the seventies. 
Here we report an 82 year-old lady who presented with balance difficulties that led to some 
loss of independence. Symptoms began at about age 80 with subsequent mild dysarthria. She 
denied any similar familial history, rending autosomal dominant disease unlikely.  On 
examination, cognition was normal, but she had hypometric ocular saccades, dysarthria, 
generally brisk deep tendon reflexes except for bilateral absent ankle jerks and a bilateral 
Babinski sign. There was also reduced ability for rapid, alternating motor tasks. There was no 
loss of sensations, including proprioception. The patient also showed important gait ataxia. The 
Scale for the Assessment and Rating of Ataxia (SARA) was rated 15 (gait: 3; stance: 1; 
sitting: 1; speech disturbance: 2; finger chase: 1; nose-finger test: 2; fast altering hand 
movements: 2; heel-sheen slide: 3). There was no pes cavus, scoliosis, deafness or diabetes. 
The nerve conduction study was normal, including amplitude of the sural nerve action 
potentials. Cardiac echography and EKG were normal. 
FA was considered as a diagnosis based on ataxia with a bilateral Babinski sign and absent 
Achilles reflexes and normal blood vitamin E levels with undetectable serum antinuclear auto-
antibodies (against Hu, Yo, Ma2, CV2/CRMP5, Ri, Tr, and GAD). The diagnosis was confirmed 
when an unstable GAA triplet expansion was demonstrated on both alleles of the FXN gene, 
with 170 and 1300 tri-nucleotides respectively. The small GAA expansion probably explains 
why the patient developed FA in her eighties, as other studies suggest a correlation between 
the size of the expanded tri-nucleotide repeats and severity of the disease and an inverse 
correlation with the age of onset 6,7.  
  
To our knowledge (excluding one possible but not proven case) 8, this lady represents the 
highest age of onset for a diagnosed FA patient. Even though FA is typically encountered in 
young patients, this report confirms that it cannot be excluded based on the advanced age of 
the patient, and should remain a possible differential diagnosis of older patients with ataxia, 
along with other genetic causes, such as SCA6 9.  
 
Author’s Roles: 
1. Vincent  Alvarez : Author of the first draft 
2. Pierre Arnold : Performed investigation critical reviewing,  
3. Thierry Kuntzer : Critical reviewing 
 
References: 
1. Schulz J. B, Boesch S, Bürk K et al. Diagnosis and treatment of Friedreich ataxia: a 
European perspective. Nat Rev Neurol. 2009; 5: 222-234. 
2. Bhidayasiri R, Perlman S.L, Pulst S-M, Geschwind D.H. Late-Onset Friedreich ataxia. Arch 
Neurol 2005; 62: 1865-1869 
3. Arnold P, Boulat O, Maire R, Kuntzer T. Expanding view of phenotype and oxidative stress 
in Friedreich’s ataxia patients with and without odebonone. Schweiz Arch Neurol Psychiatr 
2006; 157: 169-176. 
4. Glutz L and Spiegel R. Very-Late-Onset Friedreich Ataxia with Disturbing Head Tremor and 
Without Spinal Atrophy— A Case Report. Mov Disord 2008; 23: 1058. 
5. Stolle C.A, Frackelton E.C, McCallum J, Farmer J.M, Tsou A, Wilson R.B, Lynch D.R. Novel, 
Complex Interruptions of the GAA Repeat in Small, Expanded Alleles of Two Affected 
Siblings with Late-Onset Friedreich Ataxia. Mov Disord 2008; 23: 1303-1306. 
6. De Michele G, Filla A, Criscuolo C, et al. Determinants of onset age in Friedreich’s ataxia. J 
Neurol. 1998; 245: 166-168. 
7. Mateo I, Llorca J, Volpini V, Corral J, Berciano J, Combarros O. GAA expansion size and age 
at onset of Friedreich’s ataxia. Neurology. 2003; 61: 274-275. 
8. Abyad A, Kligman E. Friedreich's ataxia in the elderly. J Int Med Res. 1995; 23: 74-84. 
  
9. Fogel B and Perlman S. An approach to the patient with late-onset cerebellar ataxia. Nat 
Clin Pract Neurol. 2006; 2: 629-635. 
